CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Rising Pharma Holding, Inc. recalls Product label

Read the official FDA notice

Published
11 Mar 2026
Units affected
1200 bottles
Agency
FDA
Country
United States

The hazard

Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: Rising Pharmaceuticals, Inc., Allendale, NJ 07401, Country of origin: Taiwan, NDC 16571-816-51.

Brand / company
Rising Pharma Holding, Inc.
Codes / lots
Lot #: 1TM0524003A, Exp. Date 09/2026.
Distribution
Nationwide within the U.S
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 11 Mar 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.